We are live on ! Find out more
GGHC

Gilder Gagnon Howe & Co Portfolio holdings

AUM $9.69B
1-Year Est. Return 55.7%
This Fund
S&P 500
This Quarter Est. Return
+3.89%
1 Year Est. Return
+55.7%
3 Year Est. Return
+243.5%
5 Year Est. Return
+259.56%
10 Year Est. Return
+4,571.41%
AUM
$5.36B
AUM Growth
-$370M
Cap. Flow
-$116M
Cap. Flow %
-2.16%
Top 10 Hldgs %
30.29%
Holding
272
New
25
Increased
53
Reduced
155
Closed
28

Top Sells

Rank Stock Value
1
NVO
Novo Nordisk
NVO
+$46.5M
2
ENPH icon
Enphase Energy
ENPH
+$38.5M
3
TSLA icon
Tesla
TSLA
+$35M
4
LFG
Archaea Energy Inc.
LFG
+$29.8M
5
CALX icon
Calix
CALX
+$29.5M

Sector Composition

Rank Sector Weight
1 Technology 33.08%
2 Healthcare 19.9%
3 Consumer Discretionary 17.94%
4 Industrials 9.82%
5 Communication Services 8.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FINW icon
151
FinWise Bancorp
FINW
$180M
$3.25M 0.06%
350,445
-27,338
-7% -$250K
BRZE icon
152
Braze
BRZE
$2.83B
$3.07M 0.06%
112,458
-506
-0.4% -$14.1K
RNG icon
153
RingCentral
RNG
$5.88B
$3.01M 0.06%
84,972
+21,066
+33% +$754K
NEWP
154
New Pacific Metals
NEWP
$1.05B
$2.96M 0.06%
1,315,751
-385,745
-23% -$869K
WPM icon
155
Wheaton Precious Metals
WPM
$66.9B
$2.96M 0.06%
75,696
-509
-0.7% -$18.4K
AJRD
156
DELISTED
Aerojet Rocketdyne Holdings
AJRD
$2.92M 0.05%
+52,197
New +$2.58M
SG icon
157
Sweetgreen
SG
$830M
$2.86M 0.05%
333,915
+276,782
+484% +$4.03M
NVTA
158
DELISTED
Invitae Corporation
NVTA
$2.81M 0.05%
1,512,291
-539,578
-26% -$1.32M
GKOS icon
159
Glaukos
GKOS
$10B
$2.81M 0.05%
+64,304
New +$3.17M
MGPI icon
160
MGP Ingredients
MGPI
$307M
$2.71M 0.05%
25,491
CLFD icon
161
Clearfield
CLFD
$394M
$2.61M 0.05%
27,749
-45,457
-62% -$4.79M
BLZE icon
162
Backblaze
BLZE
$792M
$2.38M 0.04%
387,631
+81,698
+27% +$391K
PLMR icon
163
Palomar
PLMR
$3.59B
$2.38M 0.04%
52,608
-468
-0.9% -$31.9K
FWONK icon
164
Liberty Media Series C
FWONK
$23.7B
$2.37M 0.04%
41,054
-46
-0.1% -$2.63K
HEI icon
165
HEICO Corp
HEI
$41.6B
$2.33M 0.04%
15,159
-6
-0% -$934
SHLS icon
166
Shoals Technologies Group
SHLS
$1.2B
$2.32M 0.04%
94,165
-32
-0% -$773
KYMR icon
167
Kymera Therapeutics
KYMR
$9.33B
$2.25M 0.04%
90,186
+8,992
+11% +$240K
SRPT icon
168
Sarepta Therapeutics
SRPT
$2.17B
$2.2M 0.04%
17,011
-16
-0.1% -$1.85K
WFC icon
169
Wells Fargo
WFC
$273B
$2.16M 0.04%
52,330
-524
-1% -$23.2K
JPM icon
170
JPMorgan Chase
JPM
$924B
$2.13M 0.04%
15,856
BWIN
171
Baldwin Insurance Group
BWIN
$3.13B
$2.13M 0.04%
84,560
-399
-0.5% -$11K
PRTS icon
172
CarParts.com
PRTS
$67.3M
$2.03M 0.04%
32,483
-1,756
-5% -$92K
SLB icon
173
SLB Ltd
SLB
$80B
$1.96M 0.04%
+36,664
New +$1.83M
OLK
174
DELISTED
Olink Holding AB (publ) American Depositary Shares
OLK
$1.92M 0.04%
75,773
+1,889
+3% +$38K
GFS icon
175
GlobalFoundries
GFS
$23.6B
$1.89M 0.04%
35,075
-57
-0.2% -$3.33K

Similar funds

Gilder Gagnon Howe & Co's Q4 2022 Portfolio in Review

As of Q4 2022, Gilder Gagnon Howe & Co held 272 positions worth $5.36B, down 6.5% from $5.73B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Gilder Gagnon Howe & Co's Q4 2022 filing shows 25 new, 53 increased, 155 reduced and 28 closed positions. Its largest new stake was Chart Industries: 284,553 shares worth $32.8M. The largest sale was Novo Nordisk, an estimated $46.5M.

By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 32% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Gilder Gagnon Howe & Co's largest Q4 2022 buy was Chart Industries: 284,553 shares worth $32.8M.
  • Gilder Gagnon Howe & Co added most to Canadian Pacific Kansas City in Q4 2022, an estimated $80.1M increase.
  • Gilder Gagnon Howe & Co's biggest Q4 2022 reduction was Novo Nordisk, cutting an estimated $46.5M.
  • Gilder Gagnon Howe & Co fully exited Archaea Energy Inc. in Q4 2022, selling an estimated $29.8M.
  • Gilder Gagnon Howe & Co's ten largest holdings make up 30% of its $5.36B portfolio in Q4 2022.
  • Gilder Gagnon Howe & Co opened 25 new positions and closed 28 in Q4 2022.
  • Gilder Gagnon Howe & Co's portfolio value fell 6.5% quarter-over-quarter to $5.36B.

Based on Gilder Gagnon Howe & Co's 13F filing for Q4 2022, filed 14 Feb 2023.